These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8387613)

  • 1. Characterization of X-linked adrenoleukodystrophy in different biological specimens from ten Portuguese families.
    Jorge P; Quelhas D; Nogueira A
    J Inherit Metab Dis; 1993; 16(1):55-62. PubMed ID: 8387613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
    Stradomska TJ; Tylki-Szymańska A
    Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic patterns of very-long-chain fatty acids in plasma of patients with X-linked adrenoleukodystrophy.
    Paik MJ; Kim KR; Yoon HR; Kim HJ
    J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):149-57. PubMed ID: 11522057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
    Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
    Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation.
    Inoue K; Suzuki Y; Yajima S; Shimozawa N; Tomatsu S; Orii T; Kondo N
    Clin Genet; 1996 Nov; 50(5):348-52. PubMed ID: 9007322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy: impaired oxidation of very long chain fatty acids in white blood cells, cultured skin fibroblasts, and amniocytes.
    Singh I; Moser AE; Moser HW; Kishimoto Y
    Pediatr Res; 1984 Mar; 18(3):286-90. PubMed ID: 6728562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes.
    Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M
    Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controls.
    Moser AB; Kreiter N; Bezman L; Lu S; Raymond GV; Naidu S; Moser HW
    Ann Neurol; 1999 Jan; 45(1):100-10. PubMed ID: 9894883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Very long-chain fatty acids in erythrocyte membrane sphingomyelin: detection of ALD hemizygotes and heterozygotes.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Saeki Y; Sai H; Hirose G
    Neurology; 1986 Jun; 36(6):791-5. PubMed ID: 3703284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.
    Singh I; Pahan K; Khan M
    FEBS Lett; 1998 Apr; 426(3):342-6. PubMed ID: 9600263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: implication for X-adrenoleukodystrophy.
    Khan M; Pahan K; Singh AK; Singh I
    J Neurochem; 1998 Jul; 71(1):78-87. PubMed ID: 9648853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.
    Rattay TW; Rautenberg M; Söhn AS; Hengel H; Traschütz A; Röben B; Hayer SN; Schüle R; Wiethoff S; Zeltner L; Haack TB; Cegan A; Schöls L; Schleicher E; Peter A
    Sci Rep; 2020 Sep; 10(1):15093. PubMed ID: 32934269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenoleukodystrophy: diagnosis and carrier detection by determination of long-chain fatty acids in cultured fibroblasts.
    Tönshoff B; Lehnert W; Ropers HH
    Clin Genet; 1982 Jul; 22(1):25-9. PubMed ID: 7172473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreasing serum VLCFA levels in ageing X-ALD female carriers.
    Stradomska TJ; Tylki-Szymańska A
    J Inherit Metab Dis; 2001 Dec; 24(8):851-7. PubMed ID: 11916318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of female carriers of adrenoleukodystrophy.
    Moser HW; Moser AE; Trojak JE; Supplee SW
    J Pediatr; 1983 Jul; 103(1):54-9. PubMed ID: 6864396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenoleukodystrophy: clinical and biochemical manifestations in carriers.
    O'Neill BP; Moser HW; Saxena KM; Marmion LC
    Neurology; 1984 Jun; 34(6):798-801. PubMed ID: 6539445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.